Posts Tagged ‘World Medical Innovation Forum’
Two Mass General Brigham Scientists Honored for Work on Neurodegenerative and Cancer Therapies
Pictured left to right: Miceal Chamberlain, Paul Anderson, MD, PhD, Clotilde Lagier-Tourenne, MD, PhD, Li Chai, MD, Roger Kitterman, and Chris Coburn Investigators earn $10,000 awards to promote early-stage innovations presented at the 2023 World Medical Innovation Forum. At the 2023 World Medical Innovation Forum, 16 Mass General Brigham investigators presented their discoveries…
Read More2023 World Medical Innovation Forum | Day 3 Recap
On the final day of the 9th annual World Medical Innovation Forum, speakers explored therapeutic breakthroughs that can treat, potentially delay, or prevent inflammatory based diseases, and the rapid advances in immunology. The day was capped off with the annual announcement of the Disruptive Dozen. Fireside Chat | Scott Gottlieb, MD Former FDA Commissioner…
Read MoreComing Soon to a Clinic Near You: Top 12 Emerging Technologies Likely to Impact Patient Care Announced in Annual “Disruptive Dozen” from Mass General Brigham
Breakthroughs range from obesity drugs and diabetes treatment topotential new therapies for ALS and a future blood test for Alzheimer’s Disease. Boston, MA. June 14, 2023 — Mass General Brigham today revealed the annual “Disruptive Dozen,” 12 emerging technologies with the greatest potential to impact health care in the next several years. The “Disruptive Dozen”…
Read More2023 World Medical Innovation Forum | Day 2 Recap
With a focus on oncology innovation and investment, Day 2 of the Forum covered the biologic revolution in cancer treatment, small molecule discovery, and the market outlook. First Look Sessions The day opened with a conversation between Arpa Garay, Moderna’s Chief Commercial Officer, Geoff Meacham, PhD, Managing Director, Global Research for BofA Securities, and…
Read More2023 World Medical Innovation Forum | Day 1 Recap
The 2023 World Medical Innovation Forum is under way at the Westin Seaport, with more than 1,000 healthcare, industry, investment, and government leaders committed to bridge the innovation gap between scientific discovery and clinical application. First Look Sessions First Look opened the day with the latest insights on the next wave of breakthroughs in…
Read MoreConnect with global leaders in healthcare innovation at the 2023 World Medical Innovation Forum June 12-14
The annual World Medical Innovation Forum is being held in person at the Westin Seaport District in Boston this June 12 – 14, 2023. Mass General Brigham and Bank of America have partnered to create an exceptional gathering built around the breakthrough technologies and investments that will fundamentally improve patient care. The World Medical Innovation…
Read More2022 World Medical Innovation Forum | Day 3 Recap
The final day of the World Medical Innovation Forum began with a discussion on the fast-moving landscape of cell therapies for cancer. The Cell Therapy Landscape | CAR-T to Stem Cells Christina Coughlin, MD, PhD, CEO of CytoImmune, detailed three biological principles her team is factoring into their approach to developing T cell and…
Read More2022 World Medical Innovation Forum | Day 2 Recap
Day 2 of World Medical Innovation Forum kicked off with a fireside chat with FDA commissioner Robert Califf, MD. Califf, who recently began his second tour as commissioner, was asked about accelerated approval for new drugs with unvalidated biomarkers based on the opinion it is “reasonably likely” a change in these biomarkers predicts a…
Read More2022 World Medical Innovation Forum | Day 1 Recap
The 2022 World Medical Innovation Forum returned as an in-person event with a partnership between Mass General Brigham and Bank of America. Now in its eighth year, the Forum provides an unprecedented three-day immersion into the world of gene and cell therapies (GCT) and the investment opportunities emerging from this astonishing field. First Look Sessions…
Read MoreTop 12 Emerging Gene and Cell Therapy Technologies Likely to Impact Patient Care Announced in Annual “Disruptive Dozen” from Mass General Brigham
Breakthroughs range from restoration of sight and increasing the supply of donor organs, to treating brain cancer, hearing loss, and autoimmune diseases BOSTON, MA – May 4, 2022 — Mass General Brigham today revealed the annual “Disruptive Dozen,” 12 emerging gene and cell therapy (GCT) technologies with the greatest potential to impact health care in…
Read MoreMass General Brigham Awards $1 Million to Biotech Breakthroughs
Game-changing biotech innovations include new delivery system for brain cancer therapeutics, better detection of potential pregnancy complications, single-handed central line placement device, and more. BOSTON, MA – May 3, 2022 Ten biotech advancements from Mass General Brigham have been awarded Innovation Discovery Grants (IDG) in the 2022 round of awards for the highly competitive grant…
Read MoreNext Chapter For Biotech? Many Say 'Convergence' With Data Science
by WBUR June 8, 2018- So far, the digital revolution has mostly been a disappointment in health care. Doctors stare at their screens instead of us. Specialists and emergency rooms still don’t have all our records. But artificial intelligence, big data analytics and deep learning are converging on health care in a big way, information…
Read More